Articles with public access mandates - Shuji KuboLearn more
Available somewhere: 6
SAP155-Mediated Splicing of FUSE-Binding Protein-Interacting Repressor Serves as a Molecular Switch for c-myc Gene Expression
K Matsushita, T Kajiwara, M Tamura, M Satoh, N Tanaka, T Tomonaga, ...
Molecular Cancer Research 10 (6), 787-799, 2012
Mandates: US National Institutes of Health
In Vivo Stable Transduction of Humanized Liver Tissue in Chimeric Mice via High-Capacity Adenovirus–Lentivirus Hybrid Vector
S Kubo, M Kataoka, C Tateno, K Yoshizato, Y Kawasaki, T Kimura, ...
Human gene therapy 21 (1), 40-50, 2010
Mandates: US National Institutes of Health
Complete regression of human malignant mesothelioma xenografts following local injection of midkine promoter‐driven oncolytic adenovirus
S Kubo, Y Kawasaki, N Yamaoka, M Tagawa, N Kasahara, N Terada, ...
The journal of gene medicine 12 (8), 681-692, 2010
Mandates: US National Institutes of Health
Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma
Y Kawasaki, A Tamamoto, M Takagi-Kimura, Y Maeyama, N Yamaoka, ...
Cancer gene therapy 18 (8), 571-578, 2011
Mandates: US National Institutes of Health
Highly efficient tumor transduction and antitumor efficacy in experimental human malignant mesothelioma using replicating gibbon ape leukemia virus
S Kubo, M Takagi-Kimura, CR Logg, N Kasahara
Cancer gene therapy 20 (12), 671-677, 2013
Mandates: US National Institutes of Health
Adenovirus–retrovirus hybrid vectors achieve highly enhanced tumor transduction and antitumor efficacy in vivo
S Kubo, K Haga, A Tamamoto, DJ Palmer, P Ng, H Okamura, N Kasahara
Molecular Therapy 19 (1), 76-82, 2011
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program